Literature DB >> 12649178

Elevated levels of microtubule destabilizing factors in a Taxol-resistant/dependent A549 cell line with an alpha-tubulin mutation.

Laura A Martello1, Pascal Verdier-Pinard, Heng-Jia Shen, Lifeng He, Keila Torres, George A Orr, Susan Band Horwitz.   

Abstract

The A549 Taxol-resistant cell lines, A549-T12 and A549-T24, were isolated in our laboratory, and are dependent on Taxol for normal growth. The microtubules in these cells displayed increased dynamicity in the absence of Taxol. In the present study, a heterozygous point mutation in Kalpha1-tubulin was discovered at alpha379 (Ser to Ser/Arg). Although Taxol binds to beta-tubulin in the microtubule, sequencing of beta-tubulin class I did not reveal any mutations. The expression of the alpha-tubulin mutation was demonstrated using high-resolution isoelectric focusing and two-dimensional gel analysis. Both the wild-type and mutant tubulin were expressed in the Taxol-resistant cell lines. The region of alpha-tubulin that encompasses alpha379 is near the COOH terminus that has been proposed as a site of interaction with microtubule-associated protein (MAP) 4 and stathmin, a tubulin-interacting protein. In the Taxol-resistant cells, the active nonphosphorylated form of stathmin was increased approximately 2-fold, whereas the inactive phosphorylated forms were barely detected. The inactive phosphorylated forms of MAP4 were increased in the A549-T12 and A549-T24 cell lines. We hypothesize that these changes in tubulin/MAPs that result in increased microtubule instability may be related to the alpha-tubulin mutation and are compensated for by the stabilizing properties of Taxol.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12649178

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  57 in total

Review 1.  Mechanisms of Taxol resistance related to microtubules.

Authors:  George A Orr; Pascal Verdier-Pinard; Hayley McDaid; Susan Band Horwitz
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

2.  Synthesis and evaluation of 1,5-disubstituted tetrazoles as rigid analogues of combretastatin A-4 with potent antiproliferative and antitumor activity.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Maria Kimatrai Salvador; Delia Preti; Mojgan Aghazadeh Tabrizi; Andrea Brancale; Xian-Hua Fu; Jun Li; Su-Zhan Zhang; Ernest Hamel; Roberta Bortolozzi; Giuseppe Basso; Giampietro Viola
Journal:  J Med Chem       Date:  2011-12-21       Impact factor: 7.446

3.  Expression of the SEPT9_i4 isoform confers resistance to microtubule-interacting drugs.

Authors:  Alex D Chacko; Simon S McDade; Severine Chanduloy; Stewart W Church; Richard Kennedy; John Price; Peter A Hall; S E Hilary Russell
Journal:  Cell Oncol (Dordr)       Date:  2012-01-26       Impact factor: 6.730

4.  Structural evidence for cooperative microtubule stabilization by Taxol and the endogenous dynamics regulator MAP4.

Authors:  Hui Xiao; Hui Wang; Xuechun Zhang; Zongcai Tu; Chloë Bulinski; Marina Khrapunovich-Baine; Ruth Hogue Angeletti; Susan Band Horwitz
Journal:  ACS Chem Biol       Date:  2012-02-06       Impact factor: 5.100

Review 5.  Microtubule targeting agents: from biophysics to proteomics.

Authors:  D Calligaris; P Verdier-Pinard; F Devred; C Villard; D Braguer; Daniel Lafitte
Journal:  Cell Mol Life Sci       Date:  2010-01-28       Impact factor: 9.261

6.  Resistance to microtubule-stabilizing drugs involves two events: beta-tubulin mutation in one allele followed by loss of the second allele.

Authors:  Yuefang Wang; Aurora O'Brate; Wei Zhou; Paraskevi Giannakakou
Journal:  Cell Cycle       Date:  2005-12-18       Impact factor: 4.534

Review 7.  Microtubules and resistance to tubulin-binding agents.

Authors:  Maria Kavallaris
Journal:  Nat Rev Cancer       Date:  2010-02-11       Impact factor: 60.716

8.  Peloruside- and laulimalide-resistant human ovarian carcinoma cells have βI-tubulin mutations and altered expression of βII- and βIII-tubulin isotypes.

Authors:  Arun Kanakkanthara; Anja Wilmes; Aurora O'Brate; Daniel Escuin; Ariane Chan; Ada Gjyrezi; Janet Crawford; Pisana Rawson; Bronwyn Kivell; Peter T Northcote; Ernest Hamel; Paraskevi Giannakakou; John H Miller
Journal:  Mol Cancer Ther       Date:  2011-06-08       Impact factor: 6.261

9.  Characterization of a human βV-tubulin antibody and expression of this isotype in normal and malignant human tissue.

Authors:  Suzan K Chao; Yihong Wang; Pascal Verdier-Pinard; Chia-Ping H Yang; Lingling Liu; Alicia Rodriguez-Gabin; Hayley M McDaid; Susan Band Horwitz
Journal:  Cytoskeleton (Hoboken)       Date:  2012-07-02

10.  Differential activity of caspase-3 regulates susceptibility of lung and breast tumor cell lines to Paclitaxel.

Authors:  Charles Amoatey Odonkor; Samuel Achilefu
Journal:  Open Biochem J       Date:  2008-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.